# Zentrela

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/zentrela

- Industry: Healthcare
- Headquarters: Canada
- Website: www.zentrela.com
- Total disclosed funding: $0.8M
- Latest round: Seed (Feb 11, 2021)
- Investors on record: 2

## About

Founded in 2015 and based in Hamilton, Canada, Zentrela Inc. is a neurotechnology company providing a neurotechnology device that can measure the brainwaves of a person. The company was founded by Israel Gasperin and in February 2021, the company received USD 0.85 million is Seed funding from Jornic Ventures.

The company offers a neurotechnology AI-based device called "Cognalyzer®" designed to measure the effect of cannabis in the brain of a person by using an EEG test that collects brainwaves from the brain.

The company's revenue is generated from developing a brain test device that can calculate the brainwaves of a person.

The company's Seed funding will be used to further commercialize its proprietary EEG test for cannabis impairment and create a scientific database of cannabis product effects.

## Funding rounds

- Seed, Feb 11, 2021, $0.8M — Jornic Ventures
- Seed, Nov 30, 2016 — Ontario Centre of Innovation

## Investors

- Ontario Centre of Innovation (https://capitalatlas.ai/funds/ontario-centre-of-innovation) — Seed
- Jornic Ventures (https://capitalatlas.ai/funds/jornic-ventures) — Seed